Statutory Committee decisions
Set out below is the outcome of inquiries heard before the Statutory Committee of the Royal Pharmaceutical Society of Great Britain on Monday 24 April, Tuesday 25 April, Wednesday 26 April and Thursday 27 April 2006:
1. Following the resumed inquiry into a complaint by the Council of
the Society against Mustafa Hakimuddin Bhaiji (registration number 1050805),
the committee found that the Council’s allegations did not amount
to such misconduct as to render Mr Bhaiji unfit to be on the Register,
and therefore directed that no further action be taken in this matter.
The Council had alleged that the supply of methadone contrary to Regulation
16(4) of the Misuse of Drugs Regulations 2001 and the failure to make
an entry in the Controlled Drugs Register in respect of the supply of
methadone (in breach of Regulations 19(1) and 20(b) of the Misuse of
Drugs Regulations 2001) may have amounted to misconduct.
2. Following the inquiry into a complaint by the Council of the Society against
Sarju Patel (registration number 1072103), the committee resolved to issue
Mr Patel with a reprimand. The committee found proved the Council’s allegation
that the making of disparaging remarks regarding another pharmacy (contrary
to Key Responsibility 3 of the Code of Ethics and Standards) amounted to misconduct.
3. Following the new inquiry into a complaint by the Council of the Society
against Mark Derek Robinson (registration number 75404), the committee resolved
to issue Mr Robinson with a reprimand. The committee found proved the Council’s
allegations that a dispensing error involving the supply of 50ml of methadone
mixture 1mg/1ml labelled as 50ml Oramorph 10mg/5ml against a prescription calling
for 25ml of Oramorph 10mg/5ml; a second dispensing error involving the supply
of 50ml of Oramorph 10mg/5ml against the above-mentioned prescription; the
failure to contact the prescriber and/or advise the patient’s parents
to contact the prescriber and/or give the patient’s parents appropriate
advice following the discovery of these errors; the return of the wrongly dispensed
methadone to a methadone stock bottle in the knowledge that a dose of the dispensed
methadone had been consumed; and the failure to record in the Controlled Drugs
register the supply of 50ml methadone mixture 1mg/1ml, amounted to misconduct.
4. In delivering the determination of the inquiry into a complaint by the Council
of the Society against Michael Turner (previous registration number 67819),
the committee directed that Mr Turner should not be restored to the Register.
The committee found proved the Council’s allegations that the unlawful
possession of Controlled Drugs; the possession of quantities of prescription
only medicines at his home; a failure to make entries in the Controlled Drugs
register in respect of methadone and amphetamine purchases and supplies; the
unlawful supplies of methadone and/or diazepam; and providing false information
to police officers, amounted to misconduct sufficient to render Mr Turner unfit
to be restored to the Register. The committee also considered convictions for
various driving offences; two counts of the supply of class A Controlled Drugs
contrary to section 4(1) of the Misuse of Drugs Act 1971; three counts of the
supply of Class C Controlled Drugs contrary to section 4(1) of the Misuse of
Drugs Act 1971; and one count of possession of a Class B Controlled Drug contrary
to section 5 (3) of the Misuse of Drugs Act 1971 and found these convictions
proved.
5. Following an application for restoration on behalf of Michael John
Wallace Haynes (previous registration number 62305), the committee directed that Mr
Haynes should not be restored to the Register.
6. The inquiry into the case of Richard Gregory Woodroffe (registration number
68919), Margaret Rita Mary Gorman (registration number 67793), and Alan
Woodcock Ltd (company identification number 1001329) was adjourned to resume at a later
date.
The full approved determinations, together with the Notices of Inquiry,
can be found on the Statutory
Committee page of the Society’s website.
David Gomez
Secretary to the Statutory Committee |
The
Pharmaceutical Journal